Wilson M. Compton, MD, MPE

National Institute on Drug Abuse, National Institutes of Health, Bethesda, Maryland

  • 13Articles
  • 77.1KReads
  • 2005–2026Active
  • 28Collaborators
  • 384Citations

About

Wilson M. Compton, MD, MPE, is affiliated with the National Institute on Drug Abuse at the National Institutes of Health in Bethesda, Maryland. His publications from 2005 to 2026 focus on addiction, including opioid and stimulant use disorders, benzodiazepine misuse, and cannabis use among youth. He has also studied suicide, mental health treatment trends, mood and panic disorders, child and adolescent psychiatry, and the relationship between weight and psychopathology. His work frequently appears in Psychiatrist.com and often involves collaboration with researchers such as Beth Han and Nora D. Volkow.

Publications

JCP
County-Level Variation in Substance Use Disorder Service Utilization by Insurance Payers and Self-Pay
Original Research ▶ Video

County-Level Variation in Substance Use Disorder Service Utilization by Insurance Payers and Self-Pay

June 8, 2026

Across all examined payers, Medicaid funded a disproportionate share—over 50%—of SUD service expenditures.
, , , et al
JCP
Prescription Opioid Use Disorder in US Adults Reporting Prescription Opioid Use
Original Research

Prescription Opioid Use Disorder in US Adults Reporting Prescription Opioid Use

July 15, 2024

Of US adults using prescription opioids in the past year, 12.1% misused them, and 7.0% met criteria for prescription opioid use disorder.
, , , et al
JCP
Receipt of Antidepressants and Retention in Buprenorphine Treatment for OUD
Original Research

Receipt of Antidepressants and Retention in Buprenorphine Treatment for OUD

April 27, 2022

This study investigated whether receiving antidepressants increases the chance that patients with opioid use disorder will remain on buprenorphine treatment.
, , , et al
JCP
Original Research

Benzodiazepine Use, Misuse, and Use Disorders in the US

October 16, 2018

Benzodiazepines are used widely for anxiety and insomnia, but what proportion of users are misusing them? This analysis of National Surveys on Drug Use and Health data considers correlates...
, , , et al
JCP
Original Research

Prescription Opioid Use and Motivations for Misuse Among US Adults

August 14, 2018

Each year in the US, millions of people misuse prescription opioids. To combat this, it's important to understand the motivations. This analysis of data from the National Survey on...
, , , et al
JCP
Original Research

Trends in Nonmedical Use of Prescription Stimulants

October 17, 2017

Total prescription stimulant sales for adults have now surpassed those for youth, and targeting the misuse of these medications is important in order to reduce health and social consequences....
, , , et al
JCP
Article

Cannabis Use and Use Disorders Among US Youth

July 5, 2017

Cannabis laws have changed significantly in the United States over the past 20 years. How have these changes affected patterns of cannabis use? This study uses data from the...
, , , et al
JCP
Original Research

Trends in Receipt of Mental Health Treatments Among US Adults

October 26, 2016

Since 2008, significant changes in federal policies have been designed to increase access to mental health treatment. Have these changes been effective in influencing treatment-seeking patterns? Han and colleagues...
, , , et al
JCP
Article

Suicidal Ideation and Behavior Among Young Adults

June 22, 2016

While college students have been the focus of many studies on suicidal ideation and suicidal behavior, little attention has been given to their non-college-attending peers on these issues. It...
, , , et al
JCP
Letter to the Editor

Drs Han and Compton Reply

November 25, 2015

,
JCP
Article

Prevalence and Correlates of Past 12-Month Suicide Attempt Among Adults With Past-Year Suicidal Ideation in the United States

March 25, 2015

, , , et al
JCP
Original Research

Are Overweight, Obesity, and Extreme Obesity Associated With Psychopathology? Results From the National Epidemiologic Survey on Alcohol and Related Conditions.

July 16, 2007

, , , et al

Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.

Learn More About Ketamine and Psychedelics

Listen to the Podcast
The Journal of Clinical Psychiatry podcast cover with Benjamin Brody, MD

Subscribe to read
more articles

Subscribe